CRP and Hypertension: As shown in Table 2, in patients treated with rtPA, there was no significant difference in age, sex, hypertension, diabetes, uric acid, platelet count, baseline NIHSS score or any intracranial hemorrhage between the high and low hs-CRP groups (P > 0.05).